Skip to main content
. 2023 May 11;24(10):8604. doi: 10.3390/ijms24108604

Figure 3.

Figure 3

Reversing cardiac fibrosis can be a precision therapeutic strategy by blocking the activation of the reactive oxygen species (ROS) [38,39,40] system, advanced glycation end-products (AGE)-mediated [72], endothelin-1 (ET-1) [35], or the transforming growth factor beta (TGF-β) [71] pathway induced by hyperglycemia in diabetes mellitus (DM) cardiomyopathy.